UchiSearch
Brands and Their Owners
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| AFFYMAX | Affymax, Inc. | 4001 Miranda Avenue Palo Alto CA 94304 | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| AFFYMAX | Affymax, Inc. | 4001 Miranda Avenue Palo Alto CA 94304 | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| EVASENCE | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| EVASENSE | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke;EVA SENSE; |
| HEMANCE | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
|
|
|||
| HEMAREG | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| HEMATIDE | Affymax, Inc. | 4001 Miranda Avenue Palo Alto CA 94304 | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| HEMONTYS | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| HEMOVANCE | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| HEMOVIVE | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| JATHEME | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke;JA THEME; |
| JATHEME | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, renal failure, anoxia-induced cellular degeneration, and hypoxia-induced cellular degeneration; |
| OMONTYS | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| OMONTYS | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| RENAPEP | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| RENASYN | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| RENESYN | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| RENOPEP | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| VIBRENO | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
| XESSA | Affymax Pharma Limited | 20 Primrose Street The Broadgate Tower, 3rd Floor London EC2A2RS United Kingdom | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; |
Where the owner name is not linked, that owner no longer owns the brand |
|||